AN300140P
Recombinant GFAP Monoclonal Antibody
Größe
£361.80
War £402.00
- SKU:
- AN300140P
- Zusätzliche Namen:
- ZGC,etID36982,wu:fb34h,wu:fk42c,ALXDRD,GFAP,cb345,etID36982.3,FLJ42474,FLJ45472,gfapl,Glial Fibrillary Acidic Protein,Intermediate Filament Protein,wu:fb34h11,wu:fk42c12,xx:af506734,zgc:110485,wu:fb34h11,ALXDRD,cb345,etID36982.3,FLJ42474,FLJ45472,GFAP,GFAP,gfapl,Glial fibrillary acidic protein,Intermediate filament protein,wu:fk42c12,xx:af506734,zgc:110485
- Anwendung:
- WB
- Konzentration:
- 1 mg/ml
- Aufreinigung:
- Protein A Purified
- Lagerbedingungen:
- -20[o]C/-70[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Elabscience
- Host:
- Rabbit
- Reaktivitäten:
- Human
- Buffer:
- PBS
- Immunogen:
- A synthetic peptide corresponding to the center region of the human GFAP
- Klon:
- A1254
- Uniprot:
- P14136
- Synonyme:
- ALXDRD;glial fibrillary acidic protein
- Weitere Details:
- GFAP (Glial fibrillary acidic protein) is a type III intermediate filament protein. It is the major component of astrocyte intermediate filament. Defects in GFAP are a cause of Alexander disease. Alexander disease is a rare disorder of the central nervous system. It is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of Rosenthal fibers which are cytoplasmic inclusions in astrocytes. At the amino acid sequence level, human GFAP shares 91% and 90% identity with rat and mouse GFAP, respectively.
- Versandbedingungen:
- Blue Ice